0 ratings
Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition
genuine image
Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition
This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse.
Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition
Item #: 68666559

Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition

Item #: 68666559

MWK 485329

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from US

0 ratings Write a review
In stock
us Imported from USA store

QTY:

Order now and get it around Friday, July 03
Secured transactionsecured transaction

Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.

Our Top Logistics Partners
  • fedex
  • dhl
This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse.
U-Care Warranty:
None
Select a Plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified

paypal payment
visa payment
mastercard payment
Note: Step Down Voltage Transformer required for using electronics products of US store (110-120). Recommended power converters Buy Now.

What Stands Out

Innovative Treatment
Explores ketamine's transformation from a recreational substance to a viable antidepressant, providing new hope and options for those suffering from treatment-resistant depression.
Rapid Action
Highlights ketamine's unique ability to alleviate depressive symptoms within hours, contrasting sharply with traditional antidepressants that often take weeks to show effects.
Comprehensive Insights
Offers detailed analysis and research findings, equipping readers with essential knowledge about ketamine’s mechanisms, dosage, and safety, enhancing understanding for both professionals and patients.

Product Details

Shop and Buy the 1st ed. 2020 Edition of Ketamine: From Abused Drug to Rapid-Acting Antidepressant at Ubuy Malawi. Discover the potential of this groundbreaking treatment.
Publisher Springer
Publication date March 6, 2021
Edition 1st ed. 2020
Language English
Print length 196 pages
ISBN-10 9811529043
ISBN-13 978-9811529047
Item Weight 1 pounds (450 grams)
Dimensions 6.1 x 0.45 x 9.25 inches (15.5 x 1.1 x 23.5 cm)

Who Should Buy?

Suitable For
  • Mental Health Professionals

    This book provides insights into ketamine's role as an innovative treatment for depression, valuable for practitioners.

  • Researchers in Psychiatry

    Contains comprehensive data on ketamine’s effects, beneficial for those conducting studies in mental health and pharmacology.

  • Patients with Depression

    Offers informative perspectives on treatment options, aiding patients interested in understanding rapid-acting antidepressants.

Not Suitable For
  • General Audience

    May contain technical terminology that could be challenging for readers without a background in psychology or medicine.

  • Children and Adolescents

    Not suitable as it addresses complex medical and psychological topics not applicable to younger audiences.

  • Substance Abuse Patients

    While informative, it may not provide direct support for individuals struggling specifically with substance abuse issues.

Product Description

Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition

Have any Query? Chat with us

Customer Questions & Answers

  • Question: What is the primary focus of 'Ketamine: From Abused Drug to Rapid-Acting Antidepressant'?

    Answer: The book primarily discusses the evolution of ketamine from its reputation as an abused substance to its emerging role as an effective rapid-acting antidepressant. It explores the history, pharmacology, and the scientific basis for ketamine's therapeutic effects in treating depression, particularly in patients who have not responded to traditional antidepressants. The narrative includes case studies, clinical trials, and expert opinions that shed light on its innovative use in mental health treatment.
  • Question: How does ketamine act as an antidepressant?

    Answer: Ketamine acts as an antidepressant by primarily blocking the NMDA receptor, which leads to an increase in glutamate levels in the brain. This action promotes synaptogenesis, the formation of new synaptic connections, which may help in alleviating symptoms of depression. Its rapid onset of action contrasts with traditional antidepressants that may take weeks, providing a critical option for individuals in acute distress and highlighting its significance in urgent mental health interventions.
  • Question: Who is the target audience for this book?

    Answer: This book is designed for a diverse audience, including mental health professionals, researchers, and students seeking to understand the implications of ketamine in therapeutic contexts. It also appeals to individuals suffering from depression or those interested in emerging treatments. By presenting both scientific findings and subjective experiences, the book offers valuable insights for clinicians and lay readers alike.
  • Question: Are there any risks or side effects associated with ketamine treatment?

    Answer: Yes, while ketamine shows promise as a rapid-acting antidepressant, it also carries risks and potential side effects such as dissociation, increased heart rate, and potential for misuse. In clinical settings, trained professionals monitor patients to manage these effects. Understanding these risks is crucial for informed decision-making, ensuring that the benefits outweigh potential downsides for individuals considering this treatment.
  • Question: What clinical studies are referenced in the book?

    Answer: The book references a number of pivotal clinical studies that detail ketamine's effectiveness and safety profile as an antidepressant. These studies highlight various populations, treatment protocols, and outcomes, providing a comprehensive understanding of how ketamine has been evaluated in controlled settings. By examining this research, readers gain insight into the substance's therapeutic potential and the ongoing debates surrounding its use.
  • Question: What are some alternative treatments discussed for depression?

    Answer: Alternative treatments for depression discussed in the book include traditional antidepressants, psychotherapy, transcranial magnetic stimulation, and electroconvulsive therapy. This comparative analysis helps contextualize ketamine's role within a broader therapeutic landscape, illustrating how it can complement existing methods. Such discussions are beneficial for practitioners seeking to develop integrative treatment plans that fit individual patient needs.
  • Question: Can ketamine treatment be combined with other antidepressants?

    Answer: Yes, ketamine treatment can be combined with other antidepressants, particularly in cases where patients have not responded adequately to single-agent therapies. This combined approach can offer more comprehensive relief by addressing different pathways involved in depression. Clinicians often tailor treatment regimens based on a patient’s history and treatment response, providing a personalized strategy that maximizes therapeutic outcomes.
  • Question: Is this book based on empirical research?

    Answer: Yes, 'Ketamine: From Abused Drug to Rapid-Acting Antidepressant' is grounded in empirical research, featuring data from clinical trials, literature reviews, and case studies. The authors synthesize current knowledge, ensuring the information presented is both scientific and clinically relevant. This research-based framework helps readers appreciate the complexities surrounding ketamine's use while fostering evidence-informed discussions about its place in mental health treatment.
  • Question: What makes ketamine unique compared to traditional antidepressants?

    Answer: Ketamine's uniqueness lies in its rapid onset of action, often providing relief from depressive symptoms within hours, unlike traditional antidepressants that typically take weeks to work. Additionally, its mechanism of action differs, targeting the glutamatergic system rather than just serotonin or norepinephrine pathways. This distinctive profile positions ketamine as a crucial option, especially for treatment-resistant cases where rapid intervention is critical for patient stabilization.
  • Question: Where can I buy 'Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition'?

    Answer: You can purchase 'Ketamine: From Abused Drug to Rapid-Acting Antidepressant 1st ed. 2020 Edition' on Ubuy in Malawi. Ubuy provides a platform for various book titles and ensures you can find the edition you're looking for. This option allows you to access important information and insights on ketamine's role in mental health from a reputable source.

Neuroscience Editorial Review

No editorial reviews found

Customer Reviews & Ratings

4.0
1 customers ratings
  • 5 Star
    0%
  • 4 Star
    100%
  • 3 Star
    0%
  • 2 Star
    0%
  • 1 Star
    0%

Review this product

Share your thoughts with other customers

Pros

  • Offers new treatment insights
  • Well-researched and informative
  • Accessible for general readers
  • Discusses mental health benefits

Cons

  • Some sections could be more detailed.

Product Price History

Important information

  • Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
  • Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.

MWK 485329

Order now and get it around Friday, July 03

QTY:

Secured transactionsecured transaction

Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.

Our Top Logistics Partners
  • fedex
  • dhl
Fastest cross-border delivery

Features & Benefits

  • Ketamine is a highly effective treatment for depression, bipolar disorder, and suicidal behavior.
  • The book presents data from both basic research and clinical trials to support its effectiveness.
  • The book discusses countermeasures and complication management for ketamine abuse.
  • It addresses the mechanisms underlying the antidepressant and side effects of ketamine
  • New research findings suggest safer use of ketamine in patients with treatment-resistant depression.
  • It leads to the development of new antidepressants.